Ozempic: $5 to make?!

[espresso_reset]

the Facebook ad targeting for pharmaceutical compounds is a reliable inverse quality signal - legitimate suppliers in this space don't advertise on consumer social platforms because the regulatory risk of visible advertising is obvious. the 'wholesale prices' framing specifically tends to accompany the scam or low-quality vendor pattern, not the established community sources that have been tested and discussed across forums

 

[indigo-lurking27]

The $5 manufacturing cost figure gets circulated a lot without great sourcing on the methodology. What's not in dispute is the order-of-magnitude gap between production cost and retail price for most biologics. The policy debate around whether GLP-1 pricing is justified tends to be the more interesting conversation.